Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Gray

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Arthritis Research & Therapy|March 21, 2013
Perspectives on epigenetic-based immune intervention for rheumatic diseasesSteven G Gray
CNS Neuroscience & Therapeutics|July 21, 2010
Targeting histone deacetylases for the treatment of Huntington's diseaseSteven G Gray
Epigenomics|December 1, 2011
Epigenetic treatment of neurological diseaseSteven G Gray
BMC Pulmonary Medicine|May 6, 2021
Emerging avenues in immunotherapy for the management of malignant pleural mesotheliomaSteven G Gray
Epigenomics|May 10, 2014
Epigenetic-based immune intervention for rheumatic diseasesSteven G Gray
Clinical Epigenetics|June 19, 2012
Targeting Huntington's disease through histone deacetylasesSteven G Gray
Cancers|February 25, 2022
Fibrosis in Mesothelioma: Potential Role of Lysyl OxidasesLara Perryman, Steven G Gray
Translational Lung Cancer Research|March 25, 2020
Immunotherapy for mesothelioma: a critical review of current clinical trials and future perspectivesSteven G Gray, Luciano Mutti
Epigenetics|November 14, 2007
Rationale for the use of histone deacetylase inhibitors as a dual therapeutic modality in multiple sclerosisSteven G Gray, Fernando Dangond
Cells|July 26, 2020
The RNA Methyltransferase NSUN2 and Its Potential Roles in CancerAnitha Chellamuthu, Steven G Gray
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Arthritis Research & Therapy|March 21, 2013
Perspectives on epigenetic-based immune intervention for rheumatic diseasesSteven G Gray
CNS Neuroscience & Therapeutics|July 21, 2010
Targeting histone deacetylases for the treatment of Huntington's diseaseSteven G Gray
Epigenomics|December 1, 2011
Epigenetic treatment of neurological diseaseSteven G Gray
BMC Pulmonary Medicine|May 6, 2021
Emerging avenues in immunotherapy for the management of malignant pleural mesotheliomaSteven G Gray
Epigenomics|May 10, 2014
Epigenetic-based immune intervention for rheumatic diseasesSteven G Gray
Clinical Epigenetics|June 19, 2012
Targeting Huntington's disease through histone deacetylasesSteven G Gray
Cancers|February 25, 2022
Fibrosis in Mesothelioma: Potential Role of Lysyl OxidasesLara Perryman, Steven G Gray
Translational Lung Cancer Research|March 25, 2020
Immunotherapy for mesothelioma: a critical review of current clinical trials and future perspectivesSteven G Gray, Luciano Mutti
Epigenetics|November 14, 2007
Rationale for the use of histone deacetylase inhibitors as a dual therapeutic modality in multiple sclerosisSteven G Gray, Fernando Dangond
Cells|July 26, 2020
The RNA Methyltransferase NSUN2 and Its Potential Roles in CancerAnitha Chellamuthu, Steven G Gray
Pageof 11